Table 1:

Baseline patient and presentation characteristics stratified by histology

CharacteristicNo. (%)*
Seminoma
n = 192
Nonseminoma
n = 143
Age, yr, mean ± SD38.5 ± 14.532.5 ± 11.9
Histology
 Seminoma192 (100.0)55 (38.5)
 Embryonal102 (71.3)
 Yolk sac69 (48.3)
 Choriocarcinoma20 (14.0)
 Teratoma74 (51.7)
 Other20 (14.0)
pT stage
 1122 (63.5)70 (48.9)
 2+66 (34.4)52 (36.4)
 0 or unknown4 (2.1)21 (14.7)
cN stage
 0159 (82.8)92 (64.3)
 111 (5.7)11 (7.7)
 211 (5.7)19 (13.3)
 311 (5.7)21 (14.7)
M stage
 0185 (96.4)120 (83.9)
 17 (3.6)23 (16.1)
Cancer stage
 I159 (82.8)88 (61.5)
 II26 (13.5)28 (19.6)
 III7 (3.7)27 (18.9)
Treatment location
 Tom Baker Cancer Centre68 (35.4)53 (37.1)
 Cross Cancer Institute80 (41.7)60 (41.9)
 Other44 (22.9)30 (21.0)
Orchiectomy188 (97.9)130 (90.9)
Radiation therapy10 (5.2)1 (0.7)
Systemic therapy22 (11.5)51 (35.7)
  • Note: cN = node (clinical), M = metastasis, pT = tumour (pathological), SD = standard deviation, TGCT = testicular germ cell tumour.

  • * Unless otherwise indicated.